HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,819,816 | -18.2% | 266,400 | -27.3% | 0.66% | -4.1% |
| Q2 2023 | $37,684,240 | +38.1% | 366,400 | +46.6% | 0.68% | +27.4% |
| Q1 2023 | $27,285,000 | +40.2% | 250,000 | +46.2% | 0.54% | +44.1% |
| Q4 2022 | $19,459,800 | -88.4% | 171,000 | -91.9% | 0.37% | -87.8% |
| Q2 2022 | $168,178,000 | -27.2% | 2,108,555 | -4.0% | 3.05% | -18.7% |
| Q1 2022 | $231,100,000 | -14.2% | 2,196,555 | -12.1% | 3.75% | +8.2% |
| Q4 2021 | $269,406,000 | -5.8% | 2,500,055 | -4.2% | 3.46% | +10.2% |
| Q3 2021 | $285,938,000 | +4.5% | 2,610,355 | -10.7% | 3.14% | +13.5% |
| Q2 2021 | $273,631,000 | -5.5% | 2,922,155 | -7.1% | 2.77% | +2.3% |
| Q1 2021 | $289,406,000 | +31.5% | 3,144,355 | +4.5% | 2.71% | +40.5% |
| Q4 2020 | $220,090,000 | -5.8% | 3,008,755 | 0.0% | 1.93% | -34.4% |
| Q3 2020 | $233,720,000 | +46.6% | 3,008,755 | +4.9% | 2.94% | +30.9% |
| Q2 2020 | $159,398,000 | +129.8% | 2,867,910 | +22.5% | 2.24% | +92.5% |
| Q1 2020 | $69,361,000 | +21.1% | 2,341,700 | +48.0% | 1.17% | +42.5% |
| Q4 2019 | $57,279,000 | – | 1,582,300 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |